Wave Life Sciences, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Wave Life Sciences, Inc. (WVE), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are WVE insiders buying or selling?
In the last 12 months, Wave Life Sciences, Inc. insiders reported 2 open-market purchases ($54.6M) and 11 sales ($1.2M) — net buying of $53.5M. Since January 2018, Trabud has recorded 89 Form 4 filings for WVE: 8 buys ($133.8M) and 81 sells ($32.3M).
Source: SEC EDGAR Form 4
What stands out
- The largest open-market purchase in the last 12 months was $54.6M by Peter Kolchinsky (Director, 10% Owner) on Mar 31, 2026. SEC ↗
- The most recent open-market purchase was reported on Mar 31, 2026 (6 months ago).
Key Statistics (January 2018 – Aug 14, 2026)
Total Form 4 filings
89
SEC EDGAR
Insider filers
15
Insider buys (8)
$133.8M
Insider sells (81)
$32.3M
Insider sentiment
Net buyingNet insider flow of $101.6M in net buying since January 2018, and $53.5M in net buying over the last 12 months.
Recent WVE insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Heidi L Wagner | Director | Sale | 7.0K | $6.01 | $42.1K | SEC ↗ |
| Aug 14, 2026 | Adrian Rawcliffe | Director | Sale | 12.7K | $5.29 | $67.2K | SEC ↗ |
| Aug 14, 2026 | Ken Takanashi | Director | Sale | 3.9K | $6.01 | $23.2K | SEC ↗ |
| Aug 14, 2026 | Tan Aik Na | Director | Sale | 432 | $6.01 | $2.6K | SEC ↗ |
| Mar 31, 2026 | Peter Kolchinsky | Director, 10% Owner | Purchase | 8.8M | $6.23 | $54.6M | SEC ↗ |
| Feb 28, 2026 | Chris Francis | SVP, Corporate Development, Head of Emerging Areas | Sale | 33.2K | $15.05 | $499.6K | SEC ↗ |
| Feb 12, 2026 | Kyle Moran | Chief Financial Officer | Sale | 3.6K | $13.45 | $48.3K | SEC ↗ |
| Feb 12, 2026 | Paul Bolno | President and CEO | Sale | 10.5K | $13.45 | $141.0K | SEC ↗ |
| Feb 12, 2026 | Chris Francis | SVP, Corporate Development, Head of Emerging Areas | Sale | 1.9K | $13.45 | $25.3K | SEC ↗ |
| Feb 12, 2026 | Chandra Vargeese | Chief Technology Officer, Head of Platform Discovery Sciences | Sale | 3.2K | $13.45 | $43.4K | SEC ↗ |
| Jan 7, 2026 | Chris Francis | SVP, Corporate Development, Head of Emerging Areas | Sale | 9.4K | $16.03 | $150.3K | SEC ↗ |
| Nov 15, 2025 | Adrian Rawcliffe | Director | Sale | 16.1K | $6.79 | $109.4K | SEC ↗ |
| Nov 14, 2025 | Peter Kolchinsky | Director, 10% Owner | Purchase | 1.0K | $6.69 | $6.7K | SEC ↗ |
| Aug 27, 2025 | Gregory L. Verdine | Director | Sale | 10.0K | $10.00 | $100.0K | SEC ↗ |
| Aug 27, 2025 | Paul Bolno | President and CEO | Sale | 217.4K | $10.10 | $2.2M | SEC ↗ |
| Aug 20, 2025 | Tan Aik Na | Director | Sale | 21.0K | $9.25 | $194.3K | SEC ↗ |
| Aug 14, 2025 | Christian O Henry | Director | Sale | 9.7K | $8.81 | $85.2K | SEC ↗ |
| Aug 8, 2025 | Ken Takanashi | Director | Sale | 4.9K | $8.75 | $42.6K | SEC ↗ |
| Aug 8, 2025 | Tan Aik Na | Director | Sale | 1.1K | $8.75 | $9.9K | SEC ↗ |
| Jun 14, 2025 | Gregory L. Verdine | Director | Sale | 30.0K | $6.95 | $208.5K | SEC ↗ |
| Mar 22, 2025 | Christian O Henry | Director | Sale | 10.5K | $9.77 | $102.6K | SEC ↗ |
| Mar 8, 2025 | Paul Bolno | President and CEO | Sale | 169.0K | $9.57 | $1.6M | SEC ↗ |
| Nov 28, 2024 | Paul Bolno | President and CEO | Sale | 50.0K | $15.00 | $750.0K | SEC ↗ |
| Nov 16, 2024 | Paul Bolno | President and CEO | Sale | 51.2K | $14.32 | $733.7K | SEC ↗ |
| Nov 14, 2024 | Chris Francis | SVP, Corporate Development, Head of Emerging Areas | Sale | 36.0K | $16.00 | $576.0K | SEC ↗ |
Showing the 25 most recent of 89 Form 4 filings for Wave Life Sciences, Inc..
Most active WVE insiders
- Paul Bolno20 filings
- Chris Francis15 filings
- Chandra Vargeese11 filings
- Michael A. Panzara9 filings
- Kyle Moran8 filings
Ask anything about WVE insider activity
Use Trabud's AI agent to query Wave Life Sciences, Inc.'s Form 4 history in plain English — "Show me WVE CEO purchases this year" or compare it against any other ticker.
Open the AI agentWVE insider trading FAQ
Are Wave Life Sciences, Inc. insiders buying or selling?
In the last 12 months, Wave Life Sciences, Inc. insiders reported 2 open-market purchases ($54.6M) and 11 sales ($1.2M) — net buying of $53.5M. Since January 2018, Trabud has recorded 89 Form 4 filings for WVE: 8 buys ($133.8M) and 81 sells ($32.3M). Over the full record that is net buying of $101.6M.
How many insiders trade WVE stock?
15 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Wave Life Sciences, Inc.. The most recent filing was accepted on Aug 14, 2026.
Where does Trabud get WVE insider trading data?
All WVE insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.